These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17667330)

  • 1. Alcohol consumption and HIV disease progression.
    Samet JH; Cheng DM; Libman H; Nunes DP; Alperen JK; Saitz R
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):194-9. PubMed ID: 17667330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption and HIV disease progression: are they related?
    Samet JH; Horton NJ; Traphagen ET; Lyon SM; Freedberg KA
    Alcohol Clin Exp Res; 2003 May; 27(5):862-7. PubMed ID: 12766632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis C on HIV progression in adults with alcohol problems.
    Cheng DM; Nunes D; Libman H; Vidaver J; Alperen JK; Saitz R; Samet JH
    Alcohol Clin Exp Res; 2007 May; 31(5):829-36. PubMed ID: 17403066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.
    Wandera B; Tumwesigye NM; Nankabirwa JI; Kambugu AD; Mafigiri DK; Kapiga S; Sethi AK
    PLoS One; 2017; 12(6):e0180015. PubMed ID: 28665974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study.
    Cook RL; Zhou Z; Kelso-Chichetto NE; Janelle J; Morano JP; Somboonwit C; Carter W; Ibanez GE; Ennis N; Cook CL; Cohen RA; Brumback B; Bryant K
    Addict Sci Clin Pract; 2017 Sep; 12(1):22. PubMed ID: 28950912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART.
    Kahler CW; Liu T; Cioe PA; Bryant V; Pinkston MM; Kojic EM; Onen N; Baker JV; Hammer J; Brooks JT; Patel P
    AIDS Behav; 2017 Jul; 21(7):1825-1835. PubMed ID: 27392417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol use accelerates HIV disease progression.
    Baum MK; Rafie C; Lai S; Sales S; Page JB; Campa A
    AIDS Res Hum Retroviruses; 2010 May; 26(5):511-8. PubMed ID: 20455765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol consumption and HIV-1 vaginal RNA shedding among women.
    Theall KP; Amedee A; Clark RA; Dumestre J; Kissinger P
    J Stud Alcohol Drugs; 2008 May; 69(3):454-8. PubMed ID: 18432389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol use and immune reconstitution among HIV-infected patients on antiretroviral therapy in Nairobi, Kenya.
    Cagle A; McGrath C; Richardson BA; Donovan D; Sakr S; Yatich N; Ngomoa R; Chepngeno Langat A; John-Stewart G; Chung MH
    AIDS Care; 2017 Sep; 29(9):1192-1197. PubMed ID: 28132519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
    Hulgan T; Shepherd BE; Raffanti SP; Fusco JS; Beckerman R; Barkanic G; Sterling TR
    J Infect Dis; 2007 Feb; 195(3):425-31. PubMed ID: 17205482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.
    Rajasekaran S; Jeyaseelan L; Raja K; Vijila S; Krithigaipriya KA; Kuralmozhi R
    J Postgrad Med; 2009; 55(4):261-6. PubMed ID: 20083872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems.
    Cheng DM; Libman H; Bridden C; Saitz R; Samet JH
    Alcohol; 2009 Feb; 43(1):65-71. PubMed ID: 19185212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels.
    Ahdieh Grant L; Silverberg MJ; Palacio H; Minkoff H; Anastos K; Young MA; Nowicki M; Kovacs A; Cohen M; Muñoz A
    AIDS; 2001 Nov; 15(16):2101-8. PubMed ID: 11684929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study.
    Conen A; Wang Q; Glass TR; Fux CA; Thurnheer MC; Orasch C; Calmy A; Bernasconi E; Vernazza P; Weber R; Bucher HC; Battegay M; Fehr J
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):472-8. PubMed ID: 23892243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
    De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
    Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective.
    Paasche-Orlow MK; Cheng DM; Palepu A; Meli S; Faber V; Samet JH
    J Gen Intern Med; 2006 Aug; 21(8):835-40. PubMed ID: 16881943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.